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Victoria Hospital, London,  Ontario N6A 4G5, Canada) 
The destruction of appropriate target cells by cytolytic thymus-derived lym- 
phocytes (CTL)  1 is an active energy-requiring  phenomenon (1-3). In the accom- 
panying paper (4), we presented evidence that T-cell-mediated  cytolysis could be 
supported by either oxidative or glycolytic energy pathways and was in general 
strongly inhibited only in those situations in which both respiration and glycoly- 
sis were simultaneously  blocked. A particular example of  this synergistic inhibi- 
tion of CTL function was the ability of the glucose analogues 2-deoxy-D-glucose 
(2-DG) and 5-thio-D-glucose (5-SH-G) to reversibly inhibit cytolysis when oxygen 
was absent or when its utilization was metabolically blocked. In the course of 
studying these glucose analogues, however, we made the unexpected observa- 
tion that cytolysis could also be inhibited under aerobic conditions if 2-DG was 
present in  sufficient excess over glucose.  This  somewhat anomolous finding 
prompted a more complete investigation of the effect of 2-DG and other glucose 
analogues on cytolysis. The present communication demonstrates that 2-DG 
inhibits  cytolysis in  a  reversible fashion  by  competing quantitatively with 
glucose, whereas other glucose analogues such as 5-SH-G and 3~9-methylglu- 
cose fail to inhibit cytolysis under comparable conditions. Furthermore, data are 
presented to suggest that the inhibition of cytolysis by 2-DG is not related to 
energy production per se. Other possible mechanisms for the inhibitory effect of 
2-DG are discussed. 
Materials and Methods 
Mice.  Adult mice of the inbred strains C57BL/6 and DBA/2 were obtained from The Jackson 
Laboratory, Bar Harbor, Maine. 
Reagents.  2-DG,  D-glucose,  a-D(+)fucose,  2-deoxy-D-galactose,  D(+)mannose,  D(+)galactose, 
D(+)glucosamine HC1, sodium pyruvate, fl-D(-)fructose, and 3-O-methyl-a-D-glucopyranoside (3- 
O-methylglucose) were obtained from Sigma Chemical Co., St. Louis, Mo. 5-SH-G was obtained 
from Pfanstiehl Labs.,  Inc.,  Waukegan,  Ill.  All reagents were dissolved in phosphate-buffered 
saline and diluted to six times the desired final concentration immediately before use. 
Generation  of CTL.  CTL  were  generated  in  vitro  in  mixed  leukocyte  cultures  (MLC)  as 
described in the accompanying paper (4).  After 4-6 days of culture, recovered cells were washed 
* Supported by the Ontario Cancer Treatment and Research Foundation. 
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lymphocytes;  2-DG,  2-deoxy-v-glucose;  MLC, mixed  leukocyte  culture;  5-SH-G, 5-thio-D-glucose. 
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three times in glucoee-free Eagle's basal medium (BME) supplemented with 2% (vol/vol) dialyzed 
fetal calf serum and 10 mM HEPES buffer. The glucose concentration in this medium (measured 
by  the  glucose oxidase technique)  was  <5  ×  10 -e M.  Viability  was  assessed  by trypan  blue 
exclusion, and the number of viable MLC cells was adjusted to 5  ×  105/ml. 
Target Cells.  P-815 mastocytoma cells were maintained in vitro and labeled with Na~51CrO4 as 
described  previously  (5).  Labeled cells were washed  three  times in  glucose-freo BME  supple- 
mented as described above and adjusted to a final concentration of 5  ×  104 cells/ml. 
Cytolytic Assay.  The technical details of the assay and method of calculation of results were 
described in detail in the accompanying paper  (4).  Spontaneous  release in the presence of all 
reagents tested did not exceed control spontaneous release by more than 3% under the experimen- 
tal conditions employed. 
Results 
Selective Inhibition of T-Cell-Mediated Cytolysis by 2-DG.  In the accompa- 
nying communication  (4), we presented evidence that the expression of T-cell- 
mediated cytolysis was not critically dependent upon glycolytic energy produc- 
tion.  In particular,  cytolysis was not significantly inhibited when glucose was 
absent or when its utilization was blocked by the presence of equimolar concen- 
trations  of the  glucose  analogues  2-DG  and  5-SH-G.  In  the  course  of these 
experiments, however, we made the unexpected observation that cytolysis was 
completely inhibited  by 2-DG in the  absence of exogenous glucose  (Table I). 
Quantitative analysis of this phenomenon (Fig. 1) indicated that the inhibition 
was dose dependent. The concentration of 2-DG required to inhibit cytolysis by 
50% under these conditions was approximately 0.5 mM and complete inhibition 
was observed in the presence of 5 mM 2-DG. 
The effect of other glucose analogues on cytolysis in the absence of exogenous 
glucose was also investigated. As can be seen from Fig. 1, neither 5-SH-G nor 3- 
O-methylglucose inhibited cytolysis when present at the same molar concentra- 
tions as 2-DG.  Since 5-SH-G was shown in the accompanying paper  (4) to be 
quantitatively as potent an inhibitor of cytolysis as 2-DG when cellular respira- 
tion was blocked, these results raised the possibility that the inhibitory effect of 
2-DG under aerobic conditions may not be related to energy production. 
Reversibility  of Effect of 2-DG on Cytolysis.  In view of the observed inhibi- 
tion of cytolysis by 2-DG in low glucose medium, it was important to determine 
whether or not this effect was reversible. To this end, populations of MLC cells 
or labeled mastocytoma target cells in low glucose medium were incubated with 
5 mM 2-DG for 90 rain  and subsequently washed and tested in a  cytotoxicity 
assay in glucose-supplemented medium. It can be seen that the inhibitory effect 
of 2-DG on cytolysis was completely reversible upon washing (Table II). These 
studies indicated that 2-DG was not toxic under the assay conditions employed; 
however, it was not possible to determine whether the inhibitory action of 2-DG 
was directed at the CTL or target cell (or both). 
Competition between 2-DG and Glucose.  The failure to observe any signifi- 
cant  inhibitory  effect of 2-DG  on  cytolysis in  medium  containing  equimolar 
concentrations of 2-DG and glucose (Table I and accompanying paper) suggested 
a  possible competition between the two hexoses.  This possibility was investi- 
gated further by assessing cytolysis at three different concentrations of 2-DG in 
the presence or absence of various concentrations of glucose. The results of such 
an experiment  (Fig.  2) indicated that inhibition of cytolysis was dependent on 712  ENERGY  METABOLISM  AND  T-CELL-MEDIATED  CYTOLYSIS.  II 
TABLE I 
Effect of 2-DG on Cytolysis in the Presence or Absence of 
Glucose* 
Glucose  concentra- 
2-DG concentration  tion  Specific  lysis 
M  M  % 
None  5  x  10 -3  44 
5  x  10 -3  5  ×  10 -3  48 
None  <5  x  10 -6  50 
5  x  10 -3  <5  x  10 -6  0 
* MLC cells (105) were assayed for cytotoxicity in low glucose (<5 × 10 -6 
M) or glucose-supplemented  medium in the presence or absence of 5 x 
10  -3 M 2-DG. 
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FIG. i.  Selective  inhibition  of  cytolysis  by 2-DG. MLC cells  in  low  glucose  medium were 
assayed for cytotoxicity  on 51Cr-labeled  mastocytoma cells  in the presence  of various 
concentrations  of  the glucose  analogues  2-DG (O--@),  5-SH-G (A---A),  or  3-O-methylglu- 
cose  (l---l).  Data are  expressed  as  percent  inhibition  relative  to  control  in  the absence  of 
analogue  (absolute  cytolysis  45%). 
the ratio of  2-DG:glucose present and was not related to the absolute concentra- 
tion of either hexose. Interestingly, these findings are formally analogous to 
studies of  the competitive inhibition of  certain reversible enzymatic reactions. 
In fact, if cytolysis is taken to be the end result of some form of enzymatic 
activity depending upon glucose as a substrate (and therefore a quantitative 
measure of  its  reaction velocity),  the data of  such a competition experiment can 
be plotted according to the Lineweaver-Burk  formulation  (Fig. 3). Although 
formal justification  for this analogy is lacking, the results obtained are never- 
theless consistent with the possibility  that 2-DG inhibits cytolysis via competi- 
tive inhibition of some enzymatic reaction which normally utilizes  glucose (or 
metabolites of  glucose) as its  substrate. Several possible reactions which may be 
inhibited by 2-DG will be discussed later. 
Effect of Other Sugars on the Inhibition of Cytolysis by 2-DG.  In view of the 
ability of glucose to competitively  reverse  the  inhibition  of cytolysis induced  by H.  ROBSON  MacDONALD 
TABLE  rl 
Reversibility of Effect of 2-DG on CTL and/or Target Cells* 
713 
Pretreatment of cells  Percent specific 51Cr release 
MLC  Mastocytoma  i0:i$  3:1  I:I 
-  -  74  47  20 
2-DG  -  82  56  30 
-  2-DG  79  54  25 
2-DG  2-DG  82  52  25 
* MLC  cells (10~/ml) or 81Cr-labeled mastocytoma  cells (5 ×  108/ml)  in 
low glucose medium  were incubated in the presence or absence of 5 
mM  2-DG for 90 rain. All cells were then washed  and assayed for 
cytotoxicity in the combinations indicated. 
Lymphocyte:target  cell  ratio. 
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FIa.  2.  Competition between 2-DG and glucose for inhibition of cytolysis. Mixtures of 
MLC cells and 51Cr-labeled target cells in low glucose medium were assayed for cy~lysis in 
the presence of 5  x  10  .8 M  (e--e),  1  x  10  -8 M  (©--©), or 2  x  l0  -4 M  (A--A) 2-DG and 
varying concentrations of glucose as indicated.  Data are expressed as percent inhibition 
relative to control without 2-DG (absolute cytolysis 48%). 
2-DG,  it was decided to compare the effect of other sugars under these condi- 
tions. To this end, sodium pyruvate and several hexoses were added at a final 
concentration of 5 mM to mixtures of MLC cells and labeled target cells in the 
presence of 5 mM 2-DG. As can be seen from Table III, the addition of mannose 
completely reversed the inhibitory effect of 2-DG. On the contrary,  equimolar 
quantities  of pyruvate,  fructose,  fucose,  galactose,  and  glucosamine  did  not 
significantly  alter  the  degree  of inhibition  observed  in  the  presence  of the 
analogue. 
The  competition  between  2-DG  and  mannose  was  further  investigated  by 
varying the concentration of mannose or glucose added to cytolytic interactions 
inhibited  by 5  mM  2-DG.  The  results  of these  studies  demonstrated  a  dose- 
dependent reversal of inhibition that was quantitatively comparable for the two 
hexoses (Table III). 
Competition  between  Other Glucose Analogues  and 2-DG.  Although  3-O- 
methylglucose and  5-SH-G were unable to inhibit  cytolysis in the absence of 
glucose, it was nonetheless of interest to determine whether or not these other 714  ENERGY  METABOLISM  AND  T-CELL-MEDIATED  CYTOLYSIS.  II 
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FIG. 3.  Lineweaver-Burk plot  demonstrating  competitive  nature  of  inhibition  of  cytolysis 
by 2-DG. Data from the same experiment as in Fig. 2 have been used to  plot  reciprocal  of 
reaction velocity (specific  lysis)  vs. reciprocal  concentration of substrate (glucose)  for 
various concentrations  of  inhibitor  (2-DG).  Symbols are as for  Fig.  2. 
TABLE  HI 
Effect of Pyruvate and Various Hexoses on the Inhibition of 
Cytolysis by 2-DG* 
2-DG concentra-  Hexose added (concentration)  Specific 
tion  lysis 
M  M  % 
None  None  55 
5  )<  10 -3  None  0 
5  ×  10  -3  Pyruvate (5  x  10 -3)  0 
5  x  10  -3  Glucose (5  x  10  -3)  49 
5  x  10  -3  Glucose (1  x  10  -3)  29 
5  x  10  -3  Glucose (2  x  10 -4)  6 
5  x  10  -3  Mannose (5  x  10  -3)  58 
5  x  10 -3  Mannose  (1  x  10  -3)  28 
5  x  10  -3  Mannose (2  x  10 -4)  4 
5  x  10  -3  Fructose (5  x  10  -3)  0 
5  x  10  -3  Galactose (5  ×  10  -3)  1 
5  x  10  -3  Fucose (5  x  10  -3)  1 
5  x  10  -3  Glucosamine (5  x  10 -3)  2 
* MLC  cells  (10  ~) in low glucose medium were assayed for  cytotoxicity 
on 51Cr-labeled  mastocytoma cells  in the presence of 2-DG and the 
indicated  concentration of  hexose. 
analogues, like glucose, could competitively reverse the inhibitory effect of 2-DG 
on cytolysis.  To test this possibility,  MLC cells and target cells were mixed in 
low glucose medium in the presence of 1 mM 2-DG, and various concentrations 
of the other analogues were added. As in the previous competition experiments, 
various  concentrations  of  glucose  were  added  to  the  inhibited  mixtures  in W 
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Fro.  4.  Effect of other glucose analogues on the inhibition of cytolysis by 2-DG. MLC cells 
in low glucose medium were assayed for cytotoxicity in the presence of 1  ×  10 -3 M  2-DG 
alone (---) or in addition to various concentrations of glucose (A--A), 5-SH-G (I--Q), or 3- 
O-methylglucose (O--O).  Cytolysis in the absence of inhibitor was 67%. 
parallel  in  each experiment as  a  positive  control.  The  results  of a  typical 
experiment (Fig.  4) demonstrated that 3~9-methylglucose was completely un- 
able to compete with 2-DG under these conditions, whereas 5-SH-G was able to 
reverse the inhibition induced by 2-DG at concentrations comparable to those of 
glucose. 
Discussion 
The experiments described in this report demonstrate that the glucose and 
mannose  analogue 2-DG  is  a  potent  reversible  inhibitor  of T-cell-mediated 
cytolysis when low concentrations of glucose are present in the assay medium. 
In contradistinction to the results presented in the accompanying  paper (4), this 
inhibition was not dependent on the simultaneous inhibition of aerobic energy 
metabolism and  was  highly selective in  the  sense that  other  analogues of 
glucose such as 5-SH-G and 3-O-methylglucose and deoxysugar analogues such 
as 2-deoxy-D-galactose  (H. R. MacDonald, unpublished data) were not effective 
inhibitors under similar experimental conditions. Furthermore, inhibition of 
cytolysis by 2-DG could be competitively overcome by addition of either glucose 
or mannose, and by the glucose analogue 5-SH-G, but not by sodium pyruvate, 
other hexoses, or 3-O-methylglucose. These studies thus raise the possibility 
that mechanisms other than simple inhibition of energy metabolism may be 
responsible for the inhibitory effect of 2-DG observed in the present study. 
The well-documented  inhibitory effect  of 2-DG on glycolytic  energy  production 
in mammalian cells was discussed in detail in the accompanying  paper (4), and 
operational evidence for an energy-related anaerobic inhibition of cytolysis by 
the analogue was presented. Despite these results, however, several observa- 
tions suggest that the competitive inhibition ofcytolysis  by 2-DG observed under 
aerobic conditions cannot be explained in this manner. Firstly, the concentra- 
tion of 2-DG  (relative to glucose) required to inhibit cytolysis under aerobic 
conditions differs substantially from that required for inhibition when cellular 
respiration is blocked. Whereas equimolar concentrations of 2-DG and glucose 
were sufficient to block cytolysis completely in the presence of sodium azide 
(Table IV of reference 4) or under conditions of extreme hypoxia (Table III of 716  ENERGY  METABOLISM  AND  T-CELL-MEDIATED  CYTOLYSIS.  II 
reference 4), a molar ratio of 25:1 was required for complete  inhibition  of 
cytolysis by 2-DG under aerobic conditions (Fig. 2). Since the inhibition  of 
cytolysis by 2-DG in the absence of respiration is probably  a quantitative 
measure of  the capacity  of  the analogue to  inhibit  glycolytic  energy production, 
the fact that a 25-fold  molar excess was required to inhibit  cytolysis  under 
aerobic conditions  is consistent  with the possibility  that the inhibition  is not 
directly  related  to energy depletion. 
A stronger argument that the inhibitory  effect  of  2-DG on cytolysis  may be 
unrelated to  energy production comes from the parallel  studies  of  the effects  of  2- 
DG and 5-SH-G on cytolysis.  Although the metabolism of  5-SH-G has not been 
extensively  studied,  it  is  known that  the thiosugar,  like  2-DG, is  phosphorylated 
and accumulation of  its  phosphorylated derivatives  leads  to inhibition  of  phos- 
phoglucomutase and hexokinase (6).  In the accompanying paper (4),  we have 
shown that 5-SH-G inhibits  cytolysis  as well (if  not better)  than 2-DG under 
conditions  where aerobic  energy production was either  absent or metabolically 
blocked (Fig.  2  and  Table III  of  reference  4).  These findings  strongly  suggest that 
5-SH-G interferes  with glycolysis  in CTL as effectively  as 2-DG, and hence the 
failure of the thiosugar to block cytolysis  under aerobic conditions provides 
strong operational evidence that the inhibitory  action of  2-DG on CTL is not 
related to glycolytic  energy production. Furthermore, the ability  of 5-SH-G, 
itself  a potent inhibitor  of  glycolysis,  to competitively  reverse the inhibition  of 
cytolysis caused by 2-DG  (Fig. 4) is inconsistent with the hypothesis that 
glycolytic  energy production is involved. 
Additional evidence that inhibition of cytolysis by 2-DG is probably  not 
directly  related  to energy production in CTL can be inferred  by comparing the 
current results with the recent data of Michl et al. (7, 8). These workers 
demonstrated that  the inhibitory  effect  of  2-DG on Fc and complement receptor- 
mediated phagocytosis mediated by mouse peritoneal macrophages could be 
readily dissociated  from its inhibitory  effect  on cellular  ATP  generation. In 
particular,  the addition of  glucose or mannose to 2-DG-inhibited macrophages 
resulted in a restoration of their phagocytic function with no concomitant 
increase  in ATP generation. The operational  similarity  between these findings 
and the restoration  of  cytolysis  caused by the addition  of  glucose  or mannose to 
2-DG-inhibited CTL suggests strongly that ATP  generation is likewise not 
involved in the latter  phenomenon. Lack of  availability  of  purified  populations 
of  CTL for ATP measurements precludes a more direct  approach to this  ques- 
tion. 
The failure  of 3-O-methylglucose  to inhibit  cytolysis  or to competitively re- 
verse the inhibition  induced by 2-DG is  probably related  to a failure  of  CTL to 
metabolize this  analogue. In this  context,  it is known that 3-O-methylglucose 
competitively inhibits  glucose transport but is not phosphorylated  or further 
metabolized in mammalian  cells  (9, 10).  In the accompanying paper (4),  we 
showed that 3~)-methylglucose, in  contrast  to  5-SH-G or 2-DG, failed  to  inhibit 
cytolysis  under conditions  where respiration  was blocked, suggesting that the 
analogue was not effective  in interfering  with glycolytic  energy metabolism in 
CTL under these conditions.  The conclusion that T-cell-mediated  cytolysis  can 
be dissociated  from glucose transport was reached independently by Bubbers H.  ROBSON  MacDONALD  717 
and Henney (11), who observed a differential  effect  of  cytochalasin  A on cytolysis 
and glucose transport. 
If  the inhibition ofT-cell-mediated  cytolysis by 2-DG is not related to its effect 
on CTL energy production, other possible mechanisms of action of 2-DG must be 
considered. In this regard, it is noteworthy that the incorporation of 2-DG into 
glycoproteins and glycolipids has been demonstrated in mammalian cells (12, 
13),  and nucleoside-diphosphate derivatives of 2-DG have been reported (14). 
Furthermore, incorporation of 2-DG has been shown to lead to defective cell wall 
formation in yeast (15) and aberrant viral envelope glycoprotein synthesis in 
certain virus-infected mammalian cells (16, 17). In view of these findings, it 
seems possible that 2-DG is being incorporated into glycoproteins and/or glyco- 
lipids  in  CTL,  or  alternatively, as  suggested by the  competitive inhibition 
studies, metabolites of 2-DG might compete with glucose metabolites for key 
enzymes (such as glycosyl transferases) involved in normal glycoprotein biosyn- 
thesis or assembly. In either case, the net result might be a reversible change in 
CTL membrane conformation  which could be manifested as a failure of the CTL 
to recognize and/or damage its target. Consistent with this view that inhibition 
of cytolysis is related to defective glycoprotein biosynthesis is the observation 
that the inhibitory effects of 2-DG on CTL could be reversed by addition of 
glucose or mannose, but not by other hexoses (Table III).  A similar result has 
been obtained with the reversal of 2-DG-mediated inhibition of viral envelope 
glycoprotein synthesis (16, 17). In either case, the reversal of  inhibition by these 
sugars could be interpreted as a competition between their metabelites and the 
metabelites of 2-DG as glycoprotein  precursors or alternatively a competition for 
important glycosyl transferases. The ability of 5-SH-G to reverse the inhibitory 
effect of 2-DG on cytolysis could be interpreted in this context to mean that 
metabolites of  the thiosugar are formed which compete with metabolites of 2-DG 
in a similar fashion. In fact, competition between nucleoside-diphosphate deriv- 
atives of 5-SH-G and glucose has been reported (18), although the effect of this 
competition  on  membrane  glycolipids  and/or  glycoproteins  is  not  known. 
Clearly, more detailed studies of the metabolism of 5-SH-G are required before 
this hypothesis can be critically evaluated. 
Although the foregoing discussion has concentrated on the possible conse- 
quences of 2-DG metabolism in CTL, it should be noted that effects on the target 
cells cannot be excluded due to the complete reversibility of the phenomenon 
(Table II). In this context, however, we have recently demonstrated that lysis of 
the  same  mastecytoma target  cells by  alloantibody and  complement or by 
antibody-dependent cell-mediated cytotoxicity (using human peripheral blood 
lymphecytes as effector cells) is not inhibited by 2-DG under conditions where 
murine T-cell-mediated cytolysis is  completely blocked  (H.  R.  MacDonald, 
unpublished data). The latter observations are consistent with (but do not prove) 
the hypothesis that the inhibitory action of 2-DG in the present system can be 
attributed to a direct effect on CTL. 
Whatever the molecular basis of the inhibition of T-cell-mediated  cytolysis  by 
2-DG may be, it is interesting to note that the release of histamine in immediate 
hypersensitivity reactions is also inhibited by comparable concentrations of 2- 
DG in rat mast cells (19) and in human basophils (20). Furthermore, as men- 718  ENERGY  METABOLISM AND  T-CELL-MEDIATED  CYTOLYSIS.  II 
tioned  above,  recent  reports by Michl  and  his  colleagues  (7,  8) have demon- 
strated  a  similar  inhibitory  effect of 2-DG  on  Fc  and  complement  receptor- 
mediated phagocytosis by mouse peritoneal macrophages. The latter results are 
strikingly  similar to the current study in that  inhibition  of phagocytosis was 
dependent upon the presence of 2-DG in sufficient molar excess over glucose, 
and could be competitively reversed by the addition of glucose or mannose, but 
not by other hexoses.  The striking similarities between their results and ours 
raise  the possibility of previously unsuspected functional  (or structural)  rela- 
tionships between T-cell-mediated cytolysis and  other receptor-mediated  phe- 
nomena.  More  detailed  biochemical  characterization  of the  mechanisms  in- 
volved and of the receptors upon which they depend is required to critically test 
such a  possibility. 
Summary 
The effect of the hexose analogue 2-deoxy-D-glucose (2-DG) on T-cell-mediated 
cytolysis has been investigated. 2-DG inhibited cytolysis in glucose-free medium 
but not in medium containing equimolar concentrations of glucose. This inhibi- 
tion was reversible and quantitatively competitive with glucose. Among other 
natural  sugars  examined,  only mannose  competed effectively with 2-DG and 
reversed the inhibition  of cytolysis, whereas sodium pyruvate, fructose, galac- 
tose, fucose, and glucosamine were without effect. Mannose and glucose were 
equally effective in competing with 2-DG on a molar basis. When other glucose 
analogues such as 5-thio-D-glucose (5-SH-G) and 3-O-methylglucose were inves- 
tigated  under  the  same  conditions,  no  inhibition  of cytolysis was  observed; 
however, 5-SH-G (but not 3-O-methylglucose) was able to reverse the inhibitory 
effect of 2-DG in a competitive fashion. Taken together with the data presented 
in the accompanying paper,  these findings provide strong evidence that 2-DG 
inhibits T-cell-mediated cytolysis by a  mechanism that is unrelated to energy 
production. The possibility that inhibition is related to interference with mem- 
brane glycoprotein synthesis is discussed. 
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